We definitely want patients to do their part with the diet and exercise, but unfortunately, and from a practical standpoint, that itself frequently is not enough, Hong said, adding that usually by the time patients see doctors they have already failed at achieving results through those means
The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s
A randomized, double-blind, placebo-controlled hamstring-strain trial has now been registered, which is exactly the kind of study still missing from the evidence and efficacy base
It remains under active clinical evaluation for weight loss and metabolic disorders
What if there was a sweetener that could help do just that
Serena was a Ro customer before she was an ambassador, said Rahamanian, touching on how Williams started her journey with GLP-1s in January 2025